Regeneron Pharmaceuticals Inc at Guggenheim Biopharma's Next Decade Virtual Conference Transcript
Good morning, everybody, and welcome to Guggenheim Biopharma Strategy Series, Biopharma Next Decade: Views from the Top on Global Strategy and Innovation. Today, we have multiple members of the Regeneron management team, including George Yancopoulos, Chief Scientific Officer, Scientific Founder and the President; Brian Zambrowicz, SVP Functional Genomic and Chief Operation; Aris Baras, SVP, Regeneron Genetics Center; and Christos Kyratsous; VP, Research. We also have Justin Holko from the IR side on us.
The format of this session is going to be presentation by Regeneron followed by Q&A. For investors listening to the call, please feel free to e-mail me your questions at [email protected]. So with this opening remark, let me turn it over to Justin for a brief intro, and then we can go into the presentation. Justin?
Thank you, Yatin. And first things first, I'm going to try to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
